CI
CPRX icon

Cowen Inc’s Catalyst Pharmaceutical CPRX Stock Holding History

Cowen Inc’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,000
Closed -$44K – 279
2015
Q4 		$44K Buy
+18,000
New +$51.6K ﹤0.01% 287
2015
Q1 		– Sell
-106,250
Closed – – 402
2014
Q4 		$0 Hold
106,250
– – ﹤0.01% 243
2014
Q3 		$255K Buy
+106,250
New +$278K 0.03% 247

Other funds holding CPRX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cowen Inc's CPRX Position: Q1 2016 in Review

Cowen Inc sold out of Catalyst Pharmaceutical (CPRX) in Q1 2016, closing a stake of 18,000 shares — an estimated $44K sold.

Cowen Inc first reported a position in CPRX in Q3 2014 and held it in 3 quarters. The position peaked at $255K in Q3 2014. 73 funds tracked by Wall St. Rank hold CPRX as of Q1 2016.

  • Cowen Inc reported no remaining Catalyst Pharmaceutical position as of Q1 2016 after selling out during the quarter.
  • Cowen Inc sold 18,000 Catalyst Pharmaceutical shares in Q1 2016, an estimated $44K.
  • Cowen Inc first reported a position in Catalyst Pharmaceutical in Q3 2014 and held it in 3 quarters.
  • Cowen Inc's Catalyst Pharmaceutical position peaked at $255K in Q3 2014.
  • 73 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2016.

Based on Cowen Inc's 13F filing for Q1 2016, filed 16 May 2016.